Tri-ortho-cresyl phosphate (TOCP) decreases the levels of cytoskeletal proteins in hen sciatic nerve

Toxicology Letters

Volumn 152, Issue 2, 2004, Pages 139-147

  Zhao, Xiu Lan ^a   Zhu, Zhen Ping ^a   Zhang, Tian Liang ^a   Zhang, Cui Li ^a   Yu, Li Hua ^a   Xie, Ke Qin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Cytoskeletal proteins; Hens; Sciatic nerve; TOCP

Indexed keywords

ALPHA TUBULIN; BETA ACTIN; BETA TUBULIN; CYTOSKELETON PROTEIN; NEUROFILAMENT PROTEIN; PROTEIN SUBUNIT; TRI ORTHO CRESYL PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; HEN; NEUROFILAMENT; NEUROTOXICITY; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; REDUCTION; SCIATIC NERVE; SPECIES COMPARISON; WESTERN BLOTTING;

ACTINS; ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL MARKERS; CHICKENS; CYTOSKELETAL PROTEINS; FEMALE; NEUROFILAMENT PROTEINS; PLASTICIZERS; SCIATIC NERVE; TRITOLYL PHOSPHATES; TUBULIN;

ANIMALIA; ZEA MAYS;

EID: 4043053686     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2004.04.012     Document Type: Article

References (38)

1. Abou-Donia M.B., Graham D.G. Delayed neurotoxicity of O-ethyl-O-4-nitrophenyl phenylphosphonothioate: Toxic effects of single oral dose on the nervous system of hens. Toxicol. Appl. Pharmacol. 48:1979;57-66
2. Abou-Donia M.B., Lapadula D.M. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: Type I and Type II. Annu. Rev. Pharmacol. Toxicol. 30:1990;405-440
3. Abou-Donia M.B. The cytoskeleton as a target for organophosphorus ester-induced delayed neurotoxicity (OPIDN). Chem. Biol. Interact. 87:1993;383-393
4. Abou-Donia M.B. Oraganophosphorus ester induced delayed neurotoxicity. Ann. Rev. Pharmacol. Toxicol. 22:1981;511-548
5. Arbuthnott E.R., Boyd I.A., Kalu K.U. Ultrastructural dimensions of myelinated peripheral nerve fibers in the cat and their relation to conduction velocity. J. Physiol. 308:1980;125-137
6. Bischoff A. Ultrastructure of tri-ortho-cresyl phosphate poisoning in the chickens. II Studies on spinal cord alterations. Acta Neuropathol. 15:1970;142-155
7. Bischoff A. The ultrastructure of tri-ortho-cresyl phosphate in poisoning. I Studies on myelin and axonal alterations in the sciatic nerve. Acta Neuropathol. 9:1967;158-174
8. Cavanagh J.B. Peripheral nerve changes in ortho-cresyl phosphate poisoning in the cat. J. Pathol. Bacteriol. 87:1964;365-383
9. Ching G.Y., Liem R.K. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absences of preexisting cytoplasmic intermediate filaments. J. Cell Biol. 122:1993;1323-1335
10. Choudhary S., Gill K.D. Protective effect of nimodipine on dichlorvos-induced delayed neurotoxicity in rat brain (1). Biochem. Pharmacol. 62:2001;1265-1272
11. Cleveland D.W., Monteiro M.J., Wong P.C., Gill S.R., Gearhart J.D., Hoffman P.N. Involvement of neurofilaments in the radial growth of axons. J. Cell Sci. 15(suppl.):1991;85-95
12. Fuchs E., Cleveland D.W. A structural scaffolding of intermediate filaments in health and disease. Science. 279:1998;514-519
13. El-Fawal H.A., Ehrich M.F. Calpain activity in organophosphorous-induced delayed neuropathy (OPIDN): effects of a phenylalkylamine calcium channel blocker. Ann. NY. Acad. Sci. 679:1993;325-329
14. El-Fawal H.A., Correll L., Gay L., Ehrich M. Protease activity in brain, nerve, and muscle of hens given neuropathy-inducing organophosphates and a calcium channel blocker. Toxicol. Appl. Pharmacol. 103:1990;133-142
15. Fowler M.J., Flaskos J., McLean W.G., Hargreaves A.J. Effects of neuropathic and non-neuropathic isomers of tricresyl phosphate and their microsomal activation on the production of axon-like processes by differentiating mouse N2a neuroblastoma cells. J. Neurochem. 76:2001;671-678
16. Glynn P. Neural development and neurodegeneration: two faces of neuropathy target esterase. Prog. Neurobiol. 61:2000;61-74
17. Gupta R.P., Abdel-Rahman A., Jensen K.F., Abou-Donia M.B. Altered expression of neurofilament subunits in diisopropyl phosphorufluoridate (DFP)-treated hen spinal cord and their presence in axonal aggregations. Brain. Res. 878:2000;32-47
18. Gupta R.P., Abou-Donia M.B. Diisopropyl phosphorofluoridate (DFP) treatment alters calcium-activated proteinase activity and cytoskeletal proteins of the hen sciatic nerve. Brain Res. 677:1995;162-166
19. Jamal G.A. Neurological syndromes of organophosphorus compounds Adeverse. Drug. React. Toxicol. Rev. 16:1997;133-170
20. Jensen K.F., Lapadula D.M., Anderson J.K., Haykal-Coates N., Abou-Donia M.B. Anomalous phosphorylated neurofilament aggregations in central and peripheral axons of hens treated with tri-ortho-cresyl phosphate (TOCP). J. Neurosci. Res. 33:1992;455-460
21. Jortner B.S., Perkins S.K., Ehrich M. Immunohistochemicals study of phosphorylated neurofilaments during the evolution of organophosphorus ester-induced delayed neuropathy (OPIDN). Neurotoxicology. 20:1999;971-976
22. Lapadula E.S., Lapadula D.M., Abou-Donia M.B. Biochemical changes in sciatic nerve of hens treated with tri-o-cresyl phosphate: increased phosphorylation of cytoskeletal proteins. Neurochem. Int. 20:1992;247-255
23. Lee M.K., Xu Z., Wong P.C., Cleveland D.W. Neurofilaments are obligate heteropolymers in vivo. J. Cell. Biol. 122:1993;1337-1350
24. Lee M.K., Cleveland D.W. Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. Curr. Opin. Cell. Biol. 6:1994;34-40
25. Liem R.K. Molecular biology of neuronal intermediate filaments. Curr. Opin. Cell. Biol. 5:1993;12-16
26. Lopachin R.M., Lehning E.J. Mechanism of calcium entry during axon injury and degeneration. Toxicol. Appl. Pharmacol. 143:1997;233-244
27. Lotti M. The pathogenesis of organophosphate polyneuropathy. Crit. Rev. Toxicol. 21:1991;465-487
28. Lu K.R., Zhang S.L., Zhang Z.M. Clinical observation on outbreak of Tri-ortho-cresyl phosphate (TOCP) poisoning. J. Hygiene Res. 21:1992;268-271
29. Micheva K.D., Vallee A., Beaulieu C., Herman I.M., Leclerc N. Beta-Actin is confined to structures having high capacity of remodeling in developing and adult rat cerebellum. Eur. J. Neurosci. 10:1998;3785-3798
30. Morgan J.P., Penovich P. Jamaica ginger paralysis. Forty-seven-year follow-up. Arch. Neurol. 35:1978;530-532
31. Nanda S., Tapaswi P.K. Biochemical, neuropathological and behavioral studies in hens induced by acute exposure of tri-ortho-cresyl phosphate. J. Neurosci. 82:1995;243-254
32. O'Hanlon G.M., Humphreys P.D., Goldman R.S., Halstead S.K., Bullens R.W., Plop J.J., Ushkaryov Y., Willison H.J. Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury. Brain. 126:2003;2497-2509
33. Sakaguchi T., Okada M., Kitamura T., Kawasaki K. Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-dificient mutant quail. Neurosci. Lett. 153:1993;65-68
34. Suwita E., Lapadula D.M., Abou-Donia M.B. Calcium a calmodulin stimulated in vitro phosphorylation of rooster brain tubulin and MAP-2 following a single oral dose of tri-o-cresyl phosphate. Brain. Res. 374:1986;199-203
35. Wong P.C., Marszalek J., Crawford T.O., Xu Z., Hsieh S.T., Griffin J.W., Cleveland D.W. Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilaments accumulation in motor neurons. J. Cell. Biol. 130:1995;1413-1422
36. Xie K., Gupta R.P., Abou-Donia M.B. Alteration in cytoskeletal protein levels in sciatic nerve on post-treatment of diisopropyl phosphorofluoridate (DFP)-treated hen with phenylmethy lsulfonyl fluoride. Neurochem. Res. 26:2001;235-243
37. Xu Z., Dong L.Y., Cleveland D.W. Neuronal intermediate filaments: new progress on old subject. Curr. Opin. Neurobiol. 4:1994;655-661
38. Yang Y., Bauer C., Strasser G., Wollman R., Julien J.P., Fuchs E. Integrators of the cytoskeleton that stabilize microtubules. Cell. 98:1999;229-238